Project Details
| Short title | YH002004 |
|---|---|
| Acronym | YH002004 |
| Status | Active |
| Effective start/end date | 2/05/22 → 18/04/27 |
CTU A multicenter, open-label, phase I dose escalation study to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of YH002 in combination with YH001 in subjects with advanced solid tumors
- Gurney, Howard (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research